$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-24-003531 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-24-003171 Act: 33 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 8.01 Accession Number: 0001683168-24-003063 Act: 34 Size: 202 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001683168-24-002961 Act: 34 Size: 349 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-24-002359 Act: 34 Size: 4 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002283 Size: 7 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002285 Size: 7 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002290 Size: 7 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002287 Size: 7 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286 Size: 7 KB 网页链接